News blog

California’s stem cell agency to choose between investment banker and cardiologist

Cross posted from Nature Medicine’s Spoonful of Medicine blog on behalf of Elie Dolgin. CIRM nominees: Jonathan Thomas (left) and Frank Litvack (right) Six months after a bungled attempt to find a new leader, the California Institute for Regenerative Medicine (CIRM) yesterday announced two candidates to succeed Bob Klein, the architect and founding chairman of the $3 billion state stem cell agency. And with the option of electing either a bond financier or a cardiologist, the CIRM board now faces a stark choice over who will lead the San Francisco-based institute as it enters into its next phase. Klein, a 


Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.